- Home
- EVAX vs MRIN Comparison
EVAX vs MRIN Comparison
Compare EVAX & MRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- MRIN
- Stock Information
- Founded
- EVAX 2008
- MRIN 2006
- Country
- EVAX Denmark
- MRIN United States
- Employees
- EVAX N/A
- MRIN N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- MRIN EDP Services
- Sector
- EVAX Health Care
- MRIN Technology
- Exchange
- EVAX Nasdaq
- MRIN Nasdaq
- Market Cap
- EVAX 8.7M
- MRIN 6.7M
- IPO Year
- EVAX 2021
- MRIN 2013
- Fundamental
- Price
- EVAX $2.78
- MRIN $2.09
- Analyst Decision
- EVAX Strong Buy
- MRIN
- Analyst Count
- EVAX 3
- MRIN 0
- Target Price
- EVAX $33.33
- MRIN N/A
- AVG Volume (30 Days)
- EVAX 6.9M
- MRIN 17.0K
- Earning Date
- EVAX 03-26-2025
- MRIN 02-20-2025
- Dividend Yield
- EVAX N/A
- MRIN N/A
- EPS Growth
- EVAX N/A
- MRIN N/A
- EPS
- EVAX N/A
- MRIN N/A
- Revenue
- EVAX $3,295,000.00
- MRIN $16,707,999.00
- Revenue This Year
- EVAX $9,039.73
- MRIN N/A
- Revenue Next Year
- EVAX $1.47
- MRIN N/A
- P/E Ratio
- EVAX N/A
- MRIN N/A
- Revenue Growth
- EVAX N/A
- MRIN N/A
- 52 Week Low
- EVAX $2.22
- MRIN $1.44
- 52 Week High
- EVAX $22.50
- MRIN $5.45
- Technical
- Relative Strength Index (RSI)
- EVAX 41.99
- MRIN 53.39
- Support Level
- EVAX $2.30
- MRIN $2.07
- Resistance Level
- EVAX $4.05
- MRIN $2.48
- Average True Range (ATR)
- EVAX 1.10
- MRIN 0.13
- MACD
- EVAX 0.02
- MRIN 0.01
- Stochastic Oscillator
- EVAX 7.39
- MRIN 29.81
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About MRIN Marin Software Incorporated
Marin Software Inc provides a cloud-based digital advertising management solution for search, display, social, and mobile advertising channels to improve financial performance, realize efficiencies and time savings, and improve business decisions. The company's enterprise marketing software platform is offered as an integrated software-as-a-service (SaaS) solution for advertisers and agencies. Its software solution is designed to help its customers measure the effectiveness of their advertising campaigns through its reporting and analytics capabilities; and manage and execute campaigns through its user interface and underlying technology that streamlines and automates functions. All the business activity of the firm is functioned through the geographical regions of The United States.